Albion Financial Group Astrazeneca PLC Transaction History
Albion Financial Group
- $1.61 Billion
- Q3 2025
A detailed history of Albion Financial Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Albion Financial Group holds 337 shares of AZN stock, worth $30,127. This represents 0.0% of its overall portfolio holdings.
Number of Shares
337
Previous 248
35.89%
Holding current value
$30,127
Previous $17,000
47.06%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,517Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...